HK2 and glioblastoma: Our work demonstrates that targeting metabolic enzymes (SDHA, cPLA2, HK2) with specific inhibitors (EPIC, AA and 2-DG) could extremely decrease the ATP production rate in GBM cells, leading to tumor cell proliferation inhibition.